Evidence map›Paper›PMID 36271457›Full record

ArticleJournal of thrombosis and haemostasis : JTH2022

"ISTH guidelines for antithrombotic treatment in COVID-19": Reply.

Sam Schulman, Michelle Sholzberg, Alex C Spyropoulos, Ryan Zarychanski

Abstract readLetterComment
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. "ISTH guidelines for antithrombotic treatment in COVID-19": Reply.Journal of thrombosis and haemostasis : JTH · 2022
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Sam SchulmanDepartment of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-8512-9043
Michelle SholzbergDepartments of Medicine, and Laboratory Medicine and Pathobiology, St. Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-1220-0301
Alex C SpyropoulosInstitute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, New York, New York, USA.ORCID 0000-0002-3175-461X
Ryan ZarychanskiSections of Hematology/Oncology and Critical Care, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0001-9455-6138

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Fibrinolytic AgentsHumansFibrinolytic Agents

Identifiers

PMID36271457
PMCPMC9801169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.